Статті в журналах з теми "CD155"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "CD155".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Zhang, Hongpan, Zhihao Yang, Guobo Du, Lu Cao, and BangXian Tan. "CD155-Prognostic and Immunotherapeutic Implications Based on Multiple Analyses of Databases Across 33 Human Cancers." Technology in Cancer Research & Treatment 20 (January 1, 2021): 153303382098008. http://dx.doi.org/10.1177/1533033820980088.
Повний текст джерелаYoshikawa, Katsuhiro, Mitsuaki Ishida, Hirotsugu Yanai, Koji Tsuta, Mitsugu Sekimoto, and Tomoharu Sugie. "Immunohistochemical analysis of CD155 expression in triple-negative breast cancer patients." PLOS ONE 16, no. 6 (June 11, 2021): e0253176. http://dx.doi.org/10.1371/journal.pone.0253176.
Повний текст джерелаZhu, Xudong, Rongpu Liang, Tianyun Lan, Dongbing Ding, Shengxin Huang, Jun Shao, Zongheng Zheng, et al. "Tumor-associated macrophage-specific CD155 contributes to M2-phenotype transition, immunosuppression, and tumor progression in colorectal cancer." Journal for ImmunoTherapy of Cancer 10, no. 9 (September 2022): e004219. http://dx.doi.org/10.1136/jitc-2021-004219.
Повний текст джерелаMurakami, Daisuke, Kenji Matsuda, Hiromitsu Iwamoto, Yasuyuki Mitani, Yuki Mizumoto, Yuki Nakamura, Ibu Matsuzaki, et al. "Prognostic value of CD155/TIGIT expression in patients with colorectal cancer." PLOS ONE 17, no. 3 (March 24, 2022): e0265908. http://dx.doi.org/10.1371/journal.pone.0265908.
Повний текст джерелаYan, Zhang. "Increased expression of CD155 and CD112 on monocytes in septic patients (INC6P.327)." Journal of Immunology 194, no. 1_Supplement (May 1, 2015): 192.29. http://dx.doi.org/10.4049/jimmunol.194.supp.192.29.
Повний текст джерелаTang, Xiyang, Jie Yang, Anping Shi, Yanlu Xiong, Miaomiao Wen, Zhonglin Luo, Huanhuan Tian, et al. "CD155 Cooperates with PD-1/PD-L1 to Promote Proliferation of Esophageal Squamous Cancer Cells via PI3K/Akt and MAPK Signaling Pathways." Cancers 14, no. 22 (November 15, 2022): 5610. http://dx.doi.org/10.3390/cancers14225610.
Повний текст джерелаLi, Yu-Chen, Quan Zhou, Qing-Kun Song, Rui-Bin Wang, Shuzhen Lyu, Xiudong Guan, Yan-Jie Zhao, and Jiang-Ping Wu. "Overexpression of an Immune Checkpoint (CD155) in Breast Cancer Associated with Prognostic Significance and Exhausted Tumor-Infiltrating Lymphocytes: A Cohort Study." Journal of Immunology Research 2020 (January 13, 2020): 1–9. http://dx.doi.org/10.1155/2020/3948928.
Повний текст джерелаHe, Yongning, Steffen Mueller, Paul R. Chipman, Carol M. Bator, Xiaozhong Peng, Valorie D. Bowman, Suchetana Mukhopadhyay, Eckard Wimmer, Richard J. Kuhn, and Michael G. Rossmann. "Complexes of Poliovirus Serotypes with Their Common Cellular Receptor, CD155." Journal of Virology 77, no. 8 (April 15, 2003): 4827–35. http://dx.doi.org/10.1128/jvi.77.8.4827-4835.2003.
Повний текст джерелаChandramohan, Vidyalakshmi, Jeffrey D. Bryant, Hailan Piao, Stephen T. Keir, Eric S. Lipp, Michaela Lefaivre, Kathryn Perkinson, Darell D. Bigner, Matthias Gromeier, and Roger E. McLendon. "Validation of an Immunohistochemistry Assay for Detection of CD155, the Poliovirus Receptor, in Malignant Gliomas." Archives of Pathology & Laboratory Medicine 141, no. 12 (December 1, 2017): 1697–704. http://dx.doi.org/10.5858/arpa.2016-0580-oa.
Повний текст джерелаCho, Monica, Madison Phillips, Longzhen Song, Amy Erbe-Gurel, and Christian M. Capitini. "CD155 axis modulation promotes natural killer cell-mediated graft-versus-tumor effects against osteosarcoma." Journal of Immunology 208, no. 1_Supplement (May 1, 2022): 62.06. http://dx.doi.org/10.4049/jimmunol.208.supp.62.06.
Повний текст джерелаTzaridis, Theophilos, Tanja Eisemann, Augusto F. Andrade, Jennifer L. Hope, Megan M. Romero, Oren J. Becher, Nada Jabado, Linda M. Bradley, and Robert J. Wechsler-Reya. "DIPG-17. CD155 regulates cell growth and immune evasion in diffuse intrinsic pontine glioma." Neuro-Oncology 24, Supplement_1 (June 1, 2022): i21. http://dx.doi.org/10.1093/neuonc/noac079.074.
Повний текст джерелаMantovani, Stefania, Stefania Varchetta, Dalila Mele, Roberta Maiello, Matteo Donadon, Cristiana Soldani, Barbara Franceschini, et al. "Defective DNAM-1 Dependent Cytotoxicity in Hepatocellular Carcinoma-Infiltrating NK Cells." Cancers 14, no. 16 (August 22, 2022): 4060. http://dx.doi.org/10.3390/cancers14164060.
Повний текст джерелаMolfetta, Rosa, Beatrice Zitti, Mario Lecce, Nadia Domenica Milito, Helena Stabile, Cinzia Fionda, Marco Cippitelli, Angela Gismondi, Angela Santoni, and Rossella Paolini. "CD155: A Multi-Functional Molecule in Tumor Progression." International Journal of Molecular Sciences 21, no. 3 (January 30, 2020): 922. http://dx.doi.org/10.3390/ijms21030922.
Повний текст джерелаGosselin, Anne-Sophie, Yannick Simonin, Florence Guivel-Benhassine, Vincent Rincheval, Jean-Luc Vayssière, Bernard Mignotte, Florence Colbère-Garapin, Thérèse Couderc, and Bruno Blondel. "Poliovirus-Induced Apoptosis Is Reduced in Cells Expressing a Mutant CD155 Selected during Persistent Poliovirus Infection in Neuroblastoma Cells." Journal of Virology 77, no. 1 (January 1, 2003): 790–98. http://dx.doi.org/10.1128/jvi.77.1.790-798.2003.
Повний текст джерелаCho, Monica, Madison Phillips, Longzhen Song, Amy Erbe, and Christian Capitini. "147 CD155 blockade boosts alloreactive natural killer cell antitumor effects against osteosarcoma." Journal for ImmunoTherapy of Cancer 8, Suppl 3 (November 2020): A160. http://dx.doi.org/10.1136/jitc-2020-sitc2020.0147.
Повний текст джерелаNemčovičová, Ivana, and Dirk M. Zajonc. "The structure of cytomegalovirus immune modulator UL141 highlights structural Ig-fold versatility for receptor binding." Acta Crystallographica Section D Biological Crystallography 70, no. 3 (February 22, 2014): 851–62. http://dx.doi.org/10.1107/s1399004713033750.
Повний текст джерелаFittje, Pia, Angelique Hœlzemer, Wilfredo F. Garcia-Beltran, Sarah Vollmers, Annika Niehrs, Kerri Hagemann, Glòria Martrus, et al. "HIV-1 Nef-mediated downregulation of CD155 results in viral restriction by KIR2DL5+ NK cells." PLOS Pathogens 18, no. 6 (June 24, 2022): e1010572. http://dx.doi.org/10.1371/journal.ppat.1010572.
Повний текст джерелаKhan, Shaukat, Hidemi Toyoda, Melissa Linehan, Akiko Iwasaki, Akio Nomoto, Günter Bernhardt, Jeronimo Cello, and Eckard Wimmer. "Poliomyelitis in transgenic mice expressing CD155 under the control of the Tage4 promoter after oral and parenteral poliovirus inoculation." Journal of General Virology 95, no. 8 (August 1, 2014): 1668–76. http://dx.doi.org/10.1099/vir.0.064535-0.
Повний текст джерелаChen, Lihua, JiuYu Gong, Rongrong Liu, Liang Fang, Ran Zhuang, Yun Zhang, and Boquan Jin. "The unfolded protein response induces the resistance of hepatoma cells to NK cells’ cytotoxicity (178.13)." Journal of Immunology 188, no. 1_Supplement (May 1, 2012): 178.13. http://dx.doi.org/10.4049/jimmunol.188.supp.178.13.
Повний текст джерелаBaury, Béatrice, Damien Masson, Brian M. McDermott, Anne Jarry, Hervé M. Blottière, Philippe Blanchardie, Christian L. Laboisse, Patrick Lustenberger, Vincent R. Racaniello, and Marc G. Denis. "Identification of secreted CD155 isoforms." Biochemical and Biophysical Research Communications 309, no. 1 (September 2003): 175–82. http://dx.doi.org/10.1016/s0006-291x(03)01560-2.
Повний текст джерелаFreistadt, MS, and KE Eberle. "Hematopoietic cells from CD155-transgenic mice express CD155 and support poliovirus replication ex vivo." Microbial Pathogenesis 29, no. 4 (October 2000): 203–12. http://dx.doi.org/10.1006/mpat.2000.0386.
Повний текст джерелаChen, Lihua, Jiuyu Gong, Liang Fang, and Boquan Jin. "Attenuated NK cell killing to hepatoma cells increases the mortality via decreased expression levels of MICA, CD112 and CD155 during UPR (P2023)." Journal of Immunology 190, no. 1_Supplement (May 1, 2013): 53.12. http://dx.doi.org/10.4049/jimmunol.190.supp.53.12.
Повний текст джерелаSzereday, Laszlo, David U. Nagy, Beata Csiszar, Dora Kevey, Timoteus Feik, and Matyas Meggyes. "Examination of the TIGIT, CD226, CD112, and CD155 Immune Checkpoint Molecules in Peripheral Blood Mononuclear Cells in Women Diagnosed with Early-Onset Preeclampsia." Biomedicines 9, no. 11 (November 3, 2021): 1608. http://dx.doi.org/10.3390/biomedicines9111608.
Повний текст джерелаProd'homme, Virginie, Daniel M. Sugrue, Richard J. Stanton, Akio Nomoto, James Davies, Carole R. Rickards, Daniel Cochrane, Melanie Moore, Gavin W. G. Wilkinson, and Peter Tomasec. "Human cytomegalovirus UL141 promotes efficient downregulation of the natural killer cell activating ligand CD112." Journal of General Virology 91, no. 8 (August 1, 2010): 2034–39. http://dx.doi.org/10.1099/vir.0.021931-0.
Повний текст джерелаKawashima, Shusuke, Takashi Inozume, Masahito Kawazu, Toshihide Ueno, Joji Nagasaki, Etsuko Tanji, Akiko Honobe, et al. "TIGIT/CD155 axis mediates resistance to immunotherapy in patients with melanoma with the inflamed tumor microenvironment." Journal for ImmunoTherapy of Cancer 9, no. 11 (November 2021): e003134. http://dx.doi.org/10.1136/jitc-2021-003134.
Повний текст джерелаWang, Han, Jianxun Qi, Shuijun Zhang, Yan Li, Shuguang Tan, and George F. Gao. "Binding mode of the side-by-side two-IgV molecule CD226/DNAM-1 to its ligand CD155/Necl-5." Proceedings of the National Academy of Sciences 116, no. 3 (December 27, 2018): 988–96. http://dx.doi.org/10.1073/pnas.1815716116.
Повний текст джерелаLevin, Steven D., Cameron S. Brandt, Edward D. Howard, Janet Johnston, Eric Chadwick, Angela Hammond, David W. Taft, et al. "Identification and Characterization of Vstm3 as an inhibitory member of the CD28 family (90.31)." Journal of Immunology 182, no. 1_Supplement (April 1, 2009): 90.31. http://dx.doi.org/10.4049/jimmunol.182.supp.90.31.
Повний текст джерелаLupo, Kyle, and Sandro Matosevic. "130 Engineered natural killer cells reactively block TIGIT and CD73 in the GBM microenvironment." Journal for ImmunoTherapy of Cancer 9, Suppl 2 (November 2021): A139. http://dx.doi.org/10.1136/jitc-2021-sitc2021.130.
Повний текст джерелаWeiss, Tobias, Hanna Meister, Michael Weller, Charles Sentman, and Patrick Roth. "IMMU-17. TARGETING GLIOBLASTOMA WITH DNAM-1-BASED CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS." Neuro-Oncology 21, Supplement_6 (November 2019): vi122. http://dx.doi.org/10.1093/neuonc/noz175.510.
Повний текст джерелаMerrill, Melinda K., Guenter Bernhardt, John H. Sampson, Carol J. Wikstrand, Darell D. Bigner, and Matthias Gromeier. "Poliovirus receptor CD155-targeted oncolysis of glioma." Neuro-Oncology 6, no. 3 (July 1, 2004): 208–17. http://dx.doi.org/10.1215/s1152851703000577.
Повний текст джерелаWang, Yan, Ying-Li Luo, Yi-Fang Chen, Zi-Dong Lu, Yue Wang, Anna Czarna, Song Shen, Cong-Fei Xu, and Jun Wang. "Dually regulating the proliferation and the immune microenvironment of melanoma via nanoparticle-delivered siRNA targeting onco-immunologic CD155." Biomaterials Science 8, no. 23 (2020): 6683–94. http://dx.doi.org/10.1039/d0bm01420f.
Повний текст джерелаLiu, Tian, Dongliang Zhang, Yuan Zhang, Xiangsheng Xu, Bo Zhou, Liang Fang, Yun Zhang, et al. "Blocking CD226 Promotes Allogeneic Transplant Immune Tolerance and Improves Skin Graft Survival by Increasing the Frequency of Regulatory T Cells in a Murine Model." Cellular Physiology and Biochemistry 45, no. 6 (2018): 2338–50. http://dx.doi.org/10.1159/000488182.
Повний текст джерелаNahas, Myrna, Dina Stroopinsky, Marzia Capelletti, Jacalyn Rosenblatt, Shira Orr, Haider Ghiasuddin, Adam Morin, Jessica Liegel, Donald Kufe, and David E. Avigan. "CD155-Tigit Pathway Modulation in Dendritic Cell/Acute Myeloid Leukemia Fusion Vaccine Model." Blood 134, Supplement_1 (November 13, 2019): 1386. http://dx.doi.org/10.1182/blood-2019-122438.
Повний текст джерела张, 雨生. "The Expression of CD155 on Renal Cell Carcinoma Cells." Advances in Clinical Medicine 09, no. 03 (2019): 373–81. http://dx.doi.org/10.12677/acm.2019.93057.
Повний текст джерелаArruga, Francesca, Andrea Iannello, Nikolaos Ioannou, Alberto Maria Todesco, Marta Coscia, Riccardo Moia, Gianluca Gaidano, et al. "The Tigit/CD226/CD155 Immunomodulatory Axis Is Deregulated in CLL and Contributes to B-Cell Anergy." Blood 138, Supplement 1 (November 5, 2021): 3718. http://dx.doi.org/10.1182/blood-2021-150183.
Повний текст джерелаDucoin, Kathleen, Linda Bilonda-Mutala, Cécile Deleine, Romain Oger, Emilie Duchalais, Nicolas Jouand, Céline Bossard, Anne Jarry, and Nadine Gervois-Segain. "Defining the Immune Checkpoint Landscape in Human Colorectal Cancer Highlights the Relevance of the TIGIT/CD155 Axis for Optimizing Immunotherapy." Cancers 14, no. 17 (August 31, 2022): 4261. http://dx.doi.org/10.3390/cancers14174261.
Повний текст джерелаMori, Kohei, Kazumasa Matsumoto, Noriyuki Amano, Dai Koguchi, Soichiro Shimura, Masahiro Hagiwara, Yuriko Shimizu, Masaomi Ikeda, Yuichi Sato, and Masatsugu Iwamura. "Expression of Membranous CD155 Is Associated with Aggressive Phenotypes and a Poor Prognosis in Patients with Bladder Cancer." Cancers 14, no. 6 (March 19, 2022): 1576. http://dx.doi.org/10.3390/cancers14061576.
Повний текст джерелаMansorunov, Danzan, Natalya Apanovich, Pavel Apanovich, Fatimat Kipkeeva, Tatyana Muzaffarova, Anna Kuzevanova, Maxim Nikulin, Olga Malikhova, and Alexander Karpukhin. "Expression of Immune Checkpoints in Malignant Tumors: Therapy Targets and Biomarkers for the Gastric Cancer Prognosis." Diagnostics 11, no. 12 (December 16, 2021): 2370. http://dx.doi.org/10.3390/diagnostics11122370.
Повний текст джерелаZhong, Tingting, Xinghua Pang, Zhaoliang Huang, Na Chen, Xiaoping Jin, Yu Xia, Maxwell Zhongmin Wang, and Baiyong Li. "184 Two types of anti-TIGIT antibodies with distinct binding epitope and functional activities." Journal for ImmunoTherapy of Cancer 8, Suppl 3 (November 2020): A198. http://dx.doi.org/10.1136/jitc-2020-sitc2020.0184.
Повний текст джерелаVieira, Alexandre R., Ariadne Letra, Renato M. Silva, Jose M. Granjeiro, Takehiko Shimizu, Fernando A. Poletta, Juan C. Mereb, Eduardo E. Castilla, and Iêda M. Orioli. "PVR/CD155 Ala67Thr Mutation and Cleft Lip/Palate." Journal of Craniofacial Surgery 29, no. 2 (March 2018): 347–52. http://dx.doi.org/10.1097/scs.0000000000004159.
Повний текст джерелаO’Donnell, Jake S., Jason Madore, Xian-Yang Li, and Mark J. Smyth. "Tumor intrinsic and extrinsic immune functions of CD155." Seminars in Cancer Biology 65 (October 2020): 189–96. http://dx.doi.org/10.1016/j.semcancer.2019.11.013.
Повний текст джерелаTao, Liang, Chaojun Song, Chenyang Huo, Yuanjie Sun, Chunmei Zhang, Xiaohua Li, Shaojuan Yu, et al. "Anti-CD155 and anti-CD112 monoclonal antibodies conjugated to a fluorescent mesoporous silica nanosensor encapsulating rhodamine 6G and fluorescein for sensitive detection of liver cancer cells." Analyst 141, no. 16 (2016): 4933–40. http://dx.doi.org/10.1039/c5an01908g.
Повний текст джерелаWeiss, T., H. Meister, M. Weller, C. Sentman, and P. Roth. "PL2.1 Exploiting the DNAM-1 system for chimeric antigen receptor (CAR) T cell therapy of glioblastoma." Neuro-Oncology 21, Supplement_3 (August 2019): iii2. http://dx.doi.org/10.1093/neuonc/noz126.002.
Повний текст джерелаPiovesan, Dana, Alejandra Lopez, Patrick Schweickert, Ferdie Soriano, Soonweng Cho, Ada Chen, Hema Singh, et al. "258 AB308 is an anti-TIGIT antibody that enhances immune activation and anti-tumor immunity alone and in combination with other I-O therapeutic agents." Journal for ImmunoTherapy of Cancer 9, Suppl 2 (November 2021): A280. http://dx.doi.org/10.1136/jitc-2021-sitc2021.258.
Повний текст джерелаFrazier, Victoria N., Eda Holl, Michael Brown, David Boczkowski, Karenia Landa, Shelley Hwang, Matthias Gromeier, and Smita K. Nair. "Oncolytic poliovirus immunotherapy for breast cancer." Journal of Immunology 204, no. 1_Supplement (May 1, 2020): 249.25. http://dx.doi.org/10.4049/jimmunol.204.supp.249.25.
Повний текст джерелаFu, Rong, Ling Deng, Zhaoyun Liu, Hui Liu, and Zonghong Shao. "Study of Bone Marrow Mesenchymal Stem Cells Regulating NK Cells Function through Tigit/ CD226 in Patients with Multiple Myeloma." Blood 138, Supplement 1 (November 5, 2021): 2685. http://dx.doi.org/10.1182/blood-2021-152389.
Повний текст джерелаSeth, S., I. Ravens, C. W. Lee, S. Glage, A. Bleich, R. Forster, G. Bernhardt, and C. Koenecke. "Absence of CD155 aggravates acute graft-versus-host disease." Proceedings of the National Academy of Sciences 108, no. 10 (February 14, 2011): E32—E33. http://dx.doi.org/10.1073/pnas.1017969108.
Повний текст джерелаIguchi-Manaka, Akiko, Genki Okumura, Hiroshi Kojima, Yukiko Cho, Rei Hirochika, Hiroko Bando, Toyomi Sato, et al. "Increased Soluble CD155 in the Serum of Cancer Patients." PLOS ONE 11, no. 4 (April 6, 2016): e0152982. http://dx.doi.org/10.1371/journal.pone.0152982.
Повний текст джерелаMasson, D. "Overexpression of the CD155 gene in human colorectal carcinoma." Gut 49, no. 2 (August 1, 2001): 236–40. http://dx.doi.org/10.1136/gut.49.2.236.
Повний текст джерелаFreistadt, M. S., and K. E. Eberle. "Physical association between CD155 and CD44 in human monocytes." Molecular Immunology 34, no. 18 (December 1997): 1247–57. http://dx.doi.org/10.1016/s0161-5890(98)00003-0.
Повний текст джерела